Differentiated Thyroid Cancer Treatment Market Insights Video
According to Cognitive Market Research, the global Differentiated Thyroid Cancer Treatment market size was USD 502.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 22.60% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 201.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 20.8% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 150.75 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 115.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 24.6% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 25.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.0% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 10.05 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.3% from 2024 to 2031.
